Testing psilocybin (25 mg) with psilocybin against a placebo for bipolar II depression
Explore this study →
There are 2 groups in this study. Group A receives psilocybin (25 mg). Group B, the placebo group, receives psilocybin 1mg micro-dose.
Sites in Ottawa, Toronto and 1 more city
- Phase 2
- 2 groups
- Sites in Vancouver, Ottawa and 1 more city
- Recruiting
Official title: Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder
Bipolar II Depression · Lakshmi N Yatham